Redox Regulation of Cell Survival by the Thioredoxin Superfamily: an Implication of Redox Gene Therapy in the Heart

Overview

Journal Antioxid Redox Signal

Specialty Endocrinology

Date 2009 Jul 9

PMID 19583492

Citations 45

Authors

Md Kaimul Ahsan

Istvan Lekli

Diptarka Ray

Junji Yodoi

Dipak K Das

Affiliations

Soon will be listed here.

Abstract

Reactive oxygen species (ROS) are the key mediators of pathogenesis in cardiovascular diseases. Members of the thioredoxin superfamily take an active part in scavenging reactive oxygen species, thus playing an essential role in maintaining the intracellular redox status. The alteration in the expression levels of thioredoxin family members and related molecules constitute effective biomarkers in various diseases, including cardiovascular complications that involve oxidative stress. Thioredoxin, glutaredoxin, peroxiredoxin, and glutathione peroxidase, along with their isoforms, are involved in interaction with the members of metabolic and signaling pathways, thus making them attractive targets for clinical intervention. Studies with cells and transgenic animals have supported this notion and raised the hope for possible gene therapy as modern genetic medicine. Of all the molecules, thioredoxins, glutaredoxins, and peroxiredoxins are emphasized, because a growing body of evidence reveals their essential and regulatory role in several steps of redox regulation. In this review, we discuss some pertinent observations regarding their distribution, structure, functions, and interactions with the several survival- and death-signaling pathways, especially in the myocardium.

Citing Articles

Integrated Bioinformatic Analyses Reveal Thioredoxin as a Putative Marker of Cancer Stem Cells and Prognosis in Prostate Cancer.

Sugiki S, Horie T, Kunii K, Sakamoto T, Nakamura Y, Chikazawa I Cancer Inform. 2025; 24:11769351251319872.

PMID: 40008390 PMC: 11851766. DOI: 10.1177/11769351251319872.

In vitro effect of hCG on cryptorchid patients' gubernacular cells: a predictive model for adjuvant personalized therapy.

Errico A, Ambrosini G, Vinco S, Bottani E, Dalla Pozza E, Marroncelli N Cell Commun Signal. 2025; 23(1):19.

PMID: 39794843 PMC: 11724491. DOI: 10.1186/s12964-024-01979-y.

The Pivotal Role of One-Carbon Metabolism in Neoplastic Progression During the Aging Process.

Majumder A, Bano S, Nayak K Biomolecules. 2024; 14(11).

PMID: 39595564 PMC: 11591851. DOI: 10.3390/biom14111387.

Mechanistic role for mTORC1 signaling in profibrotic toxicity of low-dose cadmium.

Lee C, Lee H, Jarrell Z, Smith M, Jones D, Go Y Toxicol Appl Pharmacol. 2024; 494:117159.

PMID: 39557346 PMC: 11662996. DOI: 10.1016/j.taap.2024.117159.

Juglone-ascorbate treatment enhances reactive oxygen species mediated mitochondrial apoptosis in pancreatic cancer.

Erkoc-Kaya D, Arikoglu H, Guclu E, Dursunoglu D, Menevse E Mol Biol Rep. 2024; 51(1):340.

PMID: 38393422 DOI: 10.1007/s11033-024-09254-6.

References

Hariharan J, Hebbar P, Ranie J, Philomena , Sinha A, Datta S . Alternative forms of the human thioredoxin mRNA: identification and characterization. Gene. 1996; 173(2):265-70. DOI: 10.1016/0378-1119(96)00182-5. View

Uwayama J, Hirayama A, Yanagawa T, Warabi E, Sugimoto R, Itoh K . Tissue Prx I in the protection against Fe-NTA and the reduction of nitroxyl radicals. Biochem Biophys Res Commun. 2005; 339(1):226-31. DOI: 10.1016/j.bbrc.2005.10.192. View

Dudley J, Das S, Mukherjee S, Das D . Resveratrol, a unique phytoalexin present in red wine, delivers either survival signal or death signal to the ischemic myocardium depending on dose. J Nutr Biochem. 2008; 20(6):443-52. DOI: 10.1016/j.jnutbio.2008.05.003. View

Gasdaska J, Harney J, Gasdaska P, Powis G, Berry M . Regulation of human thioredoxin reductase expression and activity by 3'-untranslated region selenocysteine insertion sequence and mRNA instability elements. J Biol Chem. 1999; 274(36):25379-85. DOI: 10.1074/jbc.274.36.25379. View

Dai J, Wang X, Feng J, Kong W, Xu Q, Shen X . Regulatory role of thioredoxin in homocysteine-induced monocyte chemoattractant protein-1 secretion in monocytes/macrophages. FEBS Lett. 2008; 582(28):3893-8. DOI: 10.1016/j.febslet.2008.10.030. View

Lefer D, Granger D . Oxidative stress and cardiac disease. Am J Med. 2000; 109(4):315-23. DOI: 10.1016/s0002-9343(00)00467-8. View

Wingert R, Galloway J, Barut B, Foott H, Fraenkel P, Axe J . Deficiency of glutaredoxin 5 reveals Fe-S clusters are required for vertebrate haem synthesis. Nature. 2005; 436(7053):1035-39. DOI: 10.1038/nature03887. View

Sun Q, Kirnarsky L, Sherman S, Gladyshev V . Selenoprotein oxidoreductase with specificity for thioredoxin and glutathione systems. Proc Natl Acad Sci U S A. 2001; 98(7):3673-8. PMC: 31110. DOI: 10.1073/pnas.051454398. View

Gasdaska P, Gasdaska J, Cochran S, Powis G . Cloning and sequencing of a human thioredoxin reductase. FEBS Lett. 1995; 373(1):5-9. DOI: 10.1016/0014-5793(95)01003-w. View

10.

Spyrou G, Enmark E, Miranda-Vizuete A, Gustafsson J . Cloning and expression of a novel mammalian thioredoxin. J Biol Chem. 1997; 272(5):2936-41. DOI: 10.1074/jbc.272.5.2936. View

11.

Ema M, Hirota K, Mimura J, Abe H, Yodoi J, Sogawa K . Molecular mechanisms of transcription activation by HLF and HIF1alpha in response to hypoxia: their stabilization and redox signal-induced interaction with CBP/p300. EMBO J. 1999; 18(7):1905-14. PMC: 1171276. DOI: 10.1093/emboj/18.7.1905. View

12.

Zhang R, Al-Lamki R, Bai L, Streb J, Miano J, Bradley J . Thioredoxin-2 inhibits mitochondria-located ASK1-mediated apoptosis in a JNK-independent manner. Circ Res. 2004; 94(11):1483-91. DOI: 10.1161/01.RES.0000130525.37646.a7. View

13.

Zhang H, Luo Y, Zhang W, He Y, Dai S, Zhang R . Endothelial-specific expression of mitochondrial thioredoxin improves endothelial cell function and reduces atherosclerotic lesions. Am J Pathol. 2007; 170(3):1108-20. PMC: 1864879. DOI: 10.2353/ajpath.2007.060960. View

14.

Hansen J, Moriarty-Craige S, Jones D . Nuclear and cytoplasmic peroxiredoxin-1 differentially regulate NF-kappaB activities. Free Radic Biol Med. 2007; 43(2):282-8. PMC: 2096473. DOI: 10.1016/j.freeradbiomed.2007.04.029. View

15.

Lundberg M, Fernandes A, Kumar S, Holmgren A . Cellular and plasma levels of human glutaredoxin 1 and 2 detected by sensitive ELISA systems. Biochem Biophys Res Commun. 2004; 319(3):801-9. DOI: 10.1016/j.bbrc.2004.04.199. View

16.

Hashemy S, Holmgren A . Regulation of the catalytic activity and structure of human thioredoxin 1 via oxidation and S-nitrosylation of cysteine residues. J Biol Chem. 2008; 283(32):21890-8. DOI: 10.1074/jbc.M801047200. View

17.

Ago T, Yeh I, Yamamoto M, Schinke-Braun M, Brown J, Tian B . Thioredoxin1 upregulates mitochondrial proteins related to oxidative phosphorylation and TCA cycle in the heart. Antioxid Redox Signal. 2006; 8(9-10):1635-50. DOI: 10.1089/ars.2006.8.1635. View

18.

Ballinger S, Patterson C, Burow D, Conklin C, Hu Z, Reuf J . Mitochondrial integrity and function in atherogenesis. Circulation. 2002; 106(5):544-9. DOI: 10.1161/01.cir.0000023921.93743.89. View

19.

Shelton M, Mieyal J . Regulation by reversible S-glutathionylation: molecular targets implicated in inflammatory diseases. Mol Cells. 2008; 25(3):332-46. PMC: 3367451. View

20.

Mu C, Zhao J, Wang L, Song L, Zhang H, Li C . Molecular cloning and characterization of peroxiredoxin 6 from Chinese mitten crab Eriocheir sinensis. Fish Shellfish Immunol. 2008; 26(6):821-7. DOI: 10.1016/j.fsi.2008.10.006. View